ozempic is semaglutide or tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity What Do You Need to

Foundayo (orforglipron) is Eli Lilly's small-molecule oral GLP-1 receptor agonist, FDA-approved on April 1, 2026 for chronic weight management in adults with obesity or overweight with a weight-related condition

According to NICE Technology Appraisal 875, it is recommended for use within specialist weight management services for people with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and can be used for up to 2 years

It preserves lean muscle mass, improves cardiovascular fitness, supports mental health, strengthens bones, and helps maintain weight loss long-term after treatment ends

The Medication Menu Explained Semaglutide (Wegovy / Ozempic Class) Semaglutide is a GLP-1 receptor agonist dosed once weekly by subcutaneous injection